CD47 and Hydrocephalus: Reducing the secretion of pro-inflammatory cytokines, depleting macrophages, microglia, and neutrophils, or inhibiting their activation, provides a therapeutic option for hydrocephalus, e.g., CD47-blocking antibodies, mesenchymal stem cell transplantation, and minocycline [98, 159, 160, 208, 209].